Beliss Financials

BLIS

Source SEC Filings (10-K/10-Q) Updated Jan 31, 2026 Currency USD FYE April

This page shows Beliss (BLIS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BLIS FY2025 2026-04-22

Balance-sheet shrinkage has outrun any reduction in obligations, leaving the company funded by external support rather than operating resources.

From FY2024 to FY2025, total assets fell from $3.16M to $137K while current liabilities still exceeded $1.51M; that combination flipped equity from $944K to -$1.45M and shows the core constraint is balance-sheet capacity, not simply one weak earnings period.

Cash of just $24.6K against $1.51M of short-term obligations leaves almost no working-capital cushion, so the business appears to be managing immediate obligations first rather than building assets that could support normal operating slack. The current ratio moved from 0.1x in FY2024 to 0.02x in FY2025, which means near-term solvency tightened further.

Shares outstanding rose from 54.8M in FY2023 to 271.4M in FY2025 while operating cash flow was negative $424K in FY2023 and negative $341K in FY2024, indicating ownership dilution has been a financing tool when the business itself was not replenishing cash. Even reported financing inflows of $866K across FY2023-FY2024 did not translate into a stronger asset base by FY2025.

Financial Health Signals

Financial Profile 9/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Beliss's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Beliss has a moderate D/E ratio of -1.09. This balance of debt and equity financing earns a leverage score of 54/100.

Liquidity

Beliss's current ratio of 0.02 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$25K

YoY+265.2%

5Y CAGR-24.3%

Beliss held $25K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

271M

YoY+45.5%

Beliss had 271M shares outstanding in fiscal year 2025. This represents an increase of 45.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

$16K

5Y CAGR-33.5%

Beliss invested $16K in research and development in fiscal year 2025.

Share Buybacks

N/A

Capital Expenditures

N/A

BLIS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	$85K	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	$85K	N/A	N/A	N/A
R&D Expenses	$16K	N/A	$8K+4.4%	$8K-60.0%	$20K-83.3%	$120K
SG&A Expenses	N/A	$94K+17.9%	$80K-28.9%	$113K+168.2%	$42K-25.5%	$56K
Operating Income	N/A	-$384K+17.2%	-$464K	N/A	-$604K-2.0%	-$592K
Interest Expense	$71K-44.9%	$128K-73.1%	$477K	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$712K	N/A	N/A	-$584K+1.4%	-$592K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$67K	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	$67K	N/A
R&D Expenses	N/A	N/A	$6K	N/A	$6K	$0-100.0%	$4K	N/A
SG&A Expenses	$18K-96.6%	$536K+1694.0%	$30K	N/A	$72K+282.2%	$19K-86.4%	$137K	N/A
Operating Income	-$152K+78.3%	-$701K-171.6%	-$258K	N/A	-$259K-42.3%	-$182K+26.3%	-$248K	N/A
Interest Expense	$46K+14.7%	$40K+21.6%	$33K	N/A	$24K+0.8%	$24K+31.8%	$18K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$290K	N/A	-$584K	N/A	-$639K-40.8%	-$454K-4.1%	-$436K	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BLIS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$137K-95.7%	$3.2M+1907.1%	$158K+570.1%	$24K-97.5%	$923K+5.9%	$871K
Current Assets	$28K-75.2%	$112K	N/A	$5K-98.1%	$243K+144.8%	$99K
Cash & Equivalents	$25K+265.2%	$7K	N/A	$5K-98.1%	$243K+144.8%	$99K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	$67K	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.6M-28.7%	$2.2M+117.3%	$1.0M+2.9%	$993K+259.7%	$276K+145.7%	$112K
Current Liabilities	$1.5M+40.2%	$1.1M+5.7%	$1.0M+2.9%	$993K+259.7%	$276K+145.7%	$112K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.4M-253.1%	$944K+209.3%	-$864K+10.9%	-$969K-249.9%	$647K-14.8%	$759K
Retained Earnings	-$9.1M-68.7%	-$5.4M-19.6%	-$4.5M-30.2%	-$3.5M-98.5%	-$1.8M-99.0%	-$882K

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$163K+16.1%	$140K+2.6%	$137K+732.1%	$16K-99.0%	$1.6M+0.2%	$1.6M-48.5%	$3.2M+74.4%	$1.8M
Current Assets	$69K+40.8%	$49K+77.3%	$28K+68.4%	$16K+4.9%	$16K+21.4%	$13K-88.4%	$112K+104.2%	$55K
Cash & Equivalents	$25K-9.0%	$27K+11.7%	$25K+108.3%	$12K-24.7%	$16K+21.4%	$13K+91.7%	$7K	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	$67K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.8M-5.9%	$1.9M+19.1%	$1.6M+36.1%	$1.2M+10.7%	$1.1M+4.8%	$1.0M-54.8%	$2.2M+112.4%	$1.0M
Current Liabilities	$1.7M-5.6%	$1.8M+20.5%	$1.5M+30.2%	$1.2M+10.7%	$1.1M+4.8%	$1.0M-7.1%	$1.1M+3.3%	$1.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.6M+7.6%	-$1.7M-20.7%	-$1.4M-26.1%	-$1.1M-297.5%	$581K-7.2%	$626K-33.7%	$944K+22.8%	$769K
Retained Earnings	-$10.3M-2.9%	-$10.0M-9.8%	-$9.1M-8.3%	-$8.4M-29.6%	-$6.5M-10.9%	-$5.9M-8.4%	-$5.4M-8.7%	-$5.0M

BLIS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$341K+19.6%	-$424K	N/A	-$369K+17.1%	-$445K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$60K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$505K
Investing Cash Flow	N/A	N/A	-$148K	N/A	N/A	-$60K
Financing Cash Flow	N/A	$134K-81.7%	$732K	N/A	$560K+9.4%	$512K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	-$152K+22.0%	-$194K+21.8%	-$248K	N/A	-$293K-47.3%	-$199K-21.8%	-$164K-515.0%	$39K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0+100.0%	-$7K	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$149K-24.4%	$197K-26.3%	$268K	N/A	$296K+44.2%	$205K+20.6%	$170K+532.1%	-$39K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

BLIS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	100.0%	N/A	N/A	N/A
Operating Margin	N/A	N/A	-545.9%	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	-75.4%	N/A	N/A	-90.3%-12.2pp	-78.0%
Return on Assets	N/A	-22.5%	N/A	N/A	-63.3%+4.7pp	-68.0%
Current Ratio	0.02-0.1	0.10	N/A	0.00-0.9	0.880.0	0.88
Debt-to-Equity	-1.09-3.4	2.35+3.5	-1.18-0.2	-1.02-1.5	0.43+0.3	0.15
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	100.0%	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	-366.8%	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	-646.0%	N/A
Return on Equity	N/A	N/A	N/A	N/A	-110.1%-37.6pp	-72.5%-26.4pp	-46.2%	N/A
Return on Assets	-178.0%	N/A	-426.8%	N/A	-39.2%-11.3pp	-27.9%-14.1pp	-13.8%	N/A
Current Ratio	0.04+0.0	0.030.0	0.020.0	0.010.0	0.010.0	0.01-0.1	0.10+0.1	0.05
Debt-to-Equity	-1.10-0.0	-1.08+0.0	-1.09-0.1	-1.01-2.8	1.81+0.2	1.60-0.7	2.35+1.0	1.36
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Uav Corp UMAV

$443K

Philly Shipyard AKRRF

$12.7M

Dewey Electronic DEWY

$4.4M

PMB Aerospace PMBY

$32K

Cyberlux CYBL

$14.5M

Frequently Asked Questions

What are Beliss's total assets?

Beliss (BLIS) had $137K in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Beliss spend on research and development?

Beliss (BLIS) invested $16K in research and development during fiscal year 2025.

How many shares does Beliss have outstanding?

Beliss (BLIS) had 271M shares outstanding as of fiscal year 2025.

What is Beliss's current ratio?

Beliss (BLIS) had a current ratio of 0.02 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Beliss's debt-to-equity ratio?

Beliss (BLIS) had a debt-to-equity ratio of -1.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Beliss's debt-to-equity ratio negative or unusual?

Beliss (BLIS) has negative shareholder equity of -$1.4M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Beliss?

Beliss (BLIS) scores 9 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.